[] Message: United States scientists say a treat nearly 2000 species of genetic diseases will come out in 3 years, treatment of disease includes several types of cystic fibrosis and muscle atrophy.
This drug is currently named PTC124 has been adopted in mice, the early human clinical trials. Scientists believe that if a new drug, it is expected to be the earliest in 2009 for production license.
The particularity of this drug is able to correct a result thousands of disease mutations. It forces the body to ignore gene mutation, producing normal protein, not disease-causing proteins. However, patients taking the medicine must be lifelong. This drug is already part of living with genetic diseases patients achieved gratifying results.
Research group leader, United States of Li-Pennsylvania State University scientists, Vinicius said: "thousands of genetic diseases to this treatment, the drug for multiple mutations causing disease. ”
The latest research results published in the April 23, published in the journal nature, the paper says this drug for carrying a result in Duchenne muscular dystrophy mutant mouse function. In addition, the drug also Additionally 1800 kinds of genetic diseases. Scientists think that this is the study of a major breakthrough.
"Muscular Dystrophy Research" Organization of Marita-posht Mitreva, known as the result of "exciting," she said researchers are looking forward to the publication of the results of all clinical and hoped that this analysis of the prospects of the treatment methods.
No comments:
Post a Comment